"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Arena Pharmaceuticals, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals Announces Changes to Board of Directors
- Feb 16th, 2018 6:30 am
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
- Feb 14th, 2018 6:31 am
Today’s Research Reports on Trending Tickers: Arena Pharmaceuticals and VIVUS
- Feb 9th, 2018 6:30 am
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
- Feb 6th, 2018 2:30 pm
Arena Pharmaceuticals Inc (NASDAQ:ARNA): Is Healthcare Attractive Relative To NasdaqGS Peers?
- Feb 2nd, 2018 12:19 pm
Analysis: Positioning to Benefit within Alliqua BioMedical, Donegal Group, QAD, ManpowerGroup, Acorda Therapeutics, and Arena Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results
- Jan 31st, 2018 5:40 am
Arena Pharmaceuticals to Host Key Opinion Leader Event on S1P Modulation and Etrasimod in Autoimmune Diseases on January 29 in New York City
- Jan 22nd, 2018 3:04 pm
Three Interviews From the J.P. Morgan Healthcare Conference
- Jan 15th, 2018 11:09 am
Arena Pharma Upgraded Ahead Of Clinical Data Release
- Jan 3rd, 2018 2:47 pm
TODAY'S CHARTS: MoneyGram plunges on blocked deal; IBM gets an upgrade; AMD soars on Intel 'design flaw'
- Jan 3rd, 2018 10:36 am
Arena Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 10
- Dec 21st, 2017 6:30 am
Does Arena Pharmaceuticals Inc’s (NASDAQ:ARNA) 67.6% EPS Growth Reflect The Long-Term Trend?
- Dec 18th, 2017 4:35 pm
Here's What Pushed Arena Pharmaceuticals, Inc. Up 10.6% in November
- Dec 11th, 2017 9:19 am
Arena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China
- Dec 5th, 2017 6:30 am
Market Trends Toward New Normal in Arena Pharmaceuticals, National Fuel Gas, Capitol Federal Financial, Comfort Systems, National Instruments, and Navistar International — Emerging Consolidated Expectations, Analyst Ratings
- Nov 27th, 2017 5:50 am
Should You Buy Arena Pharmaceuticals Inc (ARNA) At $27.23?
- Nov 22nd, 2017 6:09 am
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARNA-US : November 15, 2017
- Nov 15th, 2017 5:50 am
Frequently Asked Questions
Terms and Conditions
Copyright © 2018 VentureLine
Website developed by Digital Solutions